- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01909674
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP
April 6, 2017 updated by: Weill Medical College of Cornell University
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Cross-over Study
Our group previously conducted a study looking at the performance of three styles of positive airway pressure masks during laboratory treatment studies for obstructive sleep apnea, and we found that patients using a full-mask mask required higher positive airway pressures than patients using nasal or nasal pillows style masks to achieve successful reduction of respiratory events.
In the current study we want to randomly assign patients to either nasal or full-face masks and then switch to a different mask (if nasal was originally chosen than the mask will be switched to full-face and vise versa) after 3-weeks of use to see if the number of respiratory events change with the different mask style.
We expect the number of respiratory events will increase with the use of full-face masks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Weill Cornell Center for Sleep Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or older
- previously diagnosed with OSA
- returning for PAP titrations at the Center for Sleep Medicine
- CPAP and titration naive
- Must have a Apnea/Hypopnea Index (AHI) of ≥ 16/hr.
Exclusion Criteria:
- Patients with ≥ 50% central apneas
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Oronasal Mask
Initial administration of oronasal CPAP mask
|
|
Experimental: Nasal Mask
Initial administration of nasal CPAP mask
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of the Effectiveness of Nasal Versus Oronasal CPAP Masks
Time Frame: 3 weeks for each mask condition
|
Total Sleep Time (TST) The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time.
TST is the total of all REM and NREM sleep in a sleep episode.
|
3 weeks for each mask condition
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
July 24, 2013
First Submitted That Met QC Criteria
July 24, 2013
First Posted (Estimate)
July 26, 2013
Study Record Updates
Last Update Posted (Actual)
May 17, 2017
Last Update Submitted That Met QC Criteria
April 6, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1108011845
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea (OSA)
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
Hospital for Special Surgery, New YorkCompletedObstructive Sleep Apnea (OSA)
-
Mayo ClinicCompletedObstructive Sleep Apnea (OSA)United States
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
-
Tufts Medical CenterRespiratory Motion, Inc.Active, not recruitingObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityTerminatedObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityCornell UniversityWithdrawn
Clinical Trials on Switch CPAP mask type
-
Fisher and Paykel HealthcareCompleted
-
Fisher and Paykel HealthcareTerminatedSleep-disordered Breathing | HypercapniaNew Zealand
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedObstructive Sleep Apnea of NewbornBrazil
-
Universitaire Ziekenhuizen KU LeuvenRecruiting
-
Rigshospitalet, DenmarkUnknown
-
ResMedCompletedObstructive Sleep ApneaAustralia
-
ResMedCompletedObstructive Sleep Apnoea (OSA)Australia
-
ResMedCompletedObstructive Sleep Apnea (OSA)Australia
-
ResMedWithdrawnObstructive Sleep Apnea (OSA)
-
Beth Israel Deaconess Medical CenterActive, not recruitingObstructive Sleep ApneaUnited States